As of late 2025, there is no FDA-approved generic version of Ozempic available in the United States
This explains why so many people choose it, despite needing careful management
2 Search strategy and inclusion criteria This mini-review was based on a targeted literature search conducted in PubMed/MEDLINE and Scopus from January 2015 to August 2025, using the keywords GLP-1 receptor agonists, exercise, physical activity, obesity, type 2 diabetes, and weight loss. Additional terms ( lean mass, body composition, insulin sensitivity, cardiometabolic, combined intervention ) were used in secondary searches
I do not remember any other CME like that
the present invention is related to a process for the preparation of semaglutide